CLONAZEPAM

CLONAZEPAM was reported 161085 times

CLONAZEPAM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EJECTION FRACTION 218 0.3752
1 SENSITISATION 275 0.3623
2 STUBBORNNESS 151 0.3503
3 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 120 0.2294
4 POLYCYSTIC OVARIES 301 0.1939
5 NASAL OEDEMA 305 0.1687
6 COGWHEEL RIGIDITY 143 0.1362
7 PSYCHIATRIC DECOMPENSATION 254 0.1299
8 AGORAPHOBIA 154 0.1125
9 RHINITIS ALLERGIC 481 0.1079
10 MULTIPLE-DRUG RESISTANCE 329 0.1060
11 SUBSTANCE USE DISORDER 334 0.1047
12 HYPOMANIA 370 0.1005
13 DRUG SCREEN NEGATIVE 163 0.0926
14 DRUG WITHDRAWAL CONVULSIONS 163 0.0916
15 MYOCLONIC EPILEPSY 139 0.0916
16 DEREALISATION 178 0.0827
17 PSYCHOMOTOR SKILLS IMPAIRED 207 0.0789
18 DISSOCIATION 539 0.0702
19 PRE-EXISTING CONDITION IMPROVED 428 0.0685
20 BIPOLAR I DISORDER 149 0.0679
21 DEPRESSION SUICIDAL 230 0.0664
22 TEARFULNESS 275 0.0639
23 PERSONALITY DISORDER 166 0.0633
24 POST-TRAUMATIC STRESS DISORDER 424 0.0632
25 SUBSTANCE ABUSE 512 0.0628
26 DEPRESSIVE SYMPTOM 219 0.0621
27 BIPOLAR DISORDER 659 0.0606
28 DRUG USE DISORDER 509 0.0605
29 COMPLETED SUICIDE 5035 0.0604
30 NEUROLEPTIC MALIGNANT SYNDROME 705 0.0594
31 MIOSIS 474 0.0590
32 TACHYPHRENIA 198 0.0571
33 GAMBLING DISORDER 154 0.0570
34 COMPULSIVE SHOPPING 117 0.0568
35 HOSTILITY 144 0.0566
36 SLEEP APNOEA SYNDROME 1055 0.0552
37 DIABETIC NEUROPATHY 273 0.0551
38 PANIC DISORDER 213 0.0549
39 JAUNDICE CHOLESTATIC 192 0.0543
40 SCHIZOPHRENIA 658 0.0541
41 PARANOIA 910 0.0527
42 DROOLING 363 0.0525
43 FEELING OF DESPAIR 241 0.0516
44 MULTIPLE DRUG OVERDOSE INTENTIONAL 166 0.0516
45 NEPHROGENIC ANAEMIA 239 0.0515
46 PANIC ATTACK 1877 0.0514
47 OBSESSIVE-COMPULSIVE DISORDER 411 0.0512
48 SEDATION 1337 0.0510
49 STOMA SITE DISCHARGE 138 0.0504
50 PSYCHOTIC DISORDER 1480 0.0501
51 MANIA 824 0.0500
52 SUSPECTED SUICIDE 232 0.0495
53 HYPERPARATHYROIDISM SECONDARY 123 0.0490
54 MAJOR DEPRESSION 358 0.0489
55 ON AND OFF PHENOMENON 270 0.0486
56 BLOOD PRESSURE SYSTOLIC ABNORMAL 120 0.0485
57 CATATONIA 252 0.0479
58 STATUS EPILEPTICUS 542 0.0479
59 POSTURE ABNORMAL 156 0.0479
60 RESTLESS LEGS SYNDROME 862 0.0474
61 HALLUCINATIONS, MIXED 199 0.0473
62 POISONING 591 0.0470
63 PSYCHOMOTOR RETARDATION 132 0.0469
64 REBOUND ACID HYPERSECRETION 142 0.0469
65 HOMICIDAL IDEATION 189 0.0466
66 TOXIC ENCEPHALOPATHY 236 0.0465
67 BLOOD PRESSURE DIASTOLIC ABNORMAL 117 0.0460
68 CLUMSINESS 124 0.0454
69 PARKINSONISM 443 0.0454
70 RESPIRATORY ARREST 1250 0.0453
71 MULTIPLE DRUG OVERDOSE 224 0.0451
72 FREEZING PHENOMENON 166 0.0448
73 DELUSION 696 0.0448
74 BRUXISM 240 0.0445
75 SEROTONIN SYNDROME 852 0.0443
76 DRUG TOLERANCE 224 0.0442
77 BRADYKINESIA 260 0.0440
78 LOGORRHOEA 155 0.0439
79 THINKING ABNORMAL 815 0.0437
80 HALLUCINATION, AUDITORY 688 0.0433
81 FIBROMYALGIA 1048 0.0431
82 LOSS OF EMPLOYMENT 130 0.0430
83 ELECTROENCEPHALOGRAM ABNORMAL 135 0.0427
84 ATAXIA 507 0.0427
85 DIABETIC COMA 119 0.0425
86 AUTONOMIC NERVOUS SYSTEM IMBALANCE 124 0.0424
87 MUSCLE RIGIDITY 507 0.0424
88 BLADDER PAIN 133 0.0419
89 AKATHISIA 568 0.0416
90 NASAL POLYPS 203 0.0412
91 SOMNAMBULISM 269 0.0409
92 SUICIDAL IDEATION 3732 0.0407
93 SALIVARY HYPERSECRETION 403 0.0402
94 PARTIAL SEIZURES 210 0.0401
95 SUICIDE ATTEMPT 2420 0.0399
96 RESPIRATORY RATE DECREASED 123 0.0391
97 SUICIDAL BEHAVIOUR 162 0.0389
98 ANXIETY DISORDER 130 0.0389
99 WITHDRAWAL SYNDROME 1602 0.0381
100 THERAPEUTIC AGENT TOXICITY 127 0.0380
101 CARPAL TUNNEL SYNDROME 533 0.0380
102 HYPOVENTILATION 124 0.0380
103 MYDRIASIS 488 0.0380
104 BEHAVIOUR DISORDER 205 0.0379
105 PANIC REACTION 273 0.0378
106 DYSKINESIA 1537 0.0378
107 GRANULOCYTOPENIA 215 0.0377
108 BRONCHIECTASIS 254 0.0377
109 HANGOVER 132 0.0375
110 CONCUSSION 289 0.0373
111 PETIT MAL EPILEPSY 190 0.0372
112 GENERALISED TONIC-CLONIC SEIZURE 612 0.0369
113 RESPIRATORY DEPRESSION 450 0.0367
114 DRUG ABUSE 3045 0.0365
115 CARDIO-RESPIRATORY ARREST 1527 0.0365
116 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 187 0.0364
117 DEPRESSION 8277 0.0363
118 HYPERREFLEXIA 125 0.0358
119 ABNORMAL BEHAVIOUR 1421 0.0358
120 COORDINATION ABNORMAL 499 0.0357
121 HYPERAMMONAEMIA 178 0.0356
122 ENURESIS 143 0.0354
123 IMPAIRED DRIVING ABILITY 401 0.0352
124 FACIAL BONES FRACTURE 127 0.0352
125 DYSTONIA 682 0.0351
126 TYPE 2 DIABETES MELLITUS 1179 0.0350
127 IMPULSIVE BEHAVIOUR 131 0.0349
128 DYSPHEMIA 153 0.0349
129 NYSTAGMUS 184 0.0346
130 HYPERACUSIS 129 0.0346
131 CRYING 1259 0.0346
132 PARANASAL SINUS DISCOMFORT 131 0.0346
133 SEIZURE 3978 0.0344
134 UNRESPONSIVE TO STIMULI 888 0.0344
135 AGITATION 2522 0.0343
136 HYPERLIPIDAEMIA 410 0.0343
137 DECREASED INTEREST 201 0.0341
138 AGGRESSION 1705 0.0340
139 MYOCLONUS 402 0.0337
140 ANGER 1128 0.0333
141 RESTLESSNESS 1213 0.0331
142 SCREAMING 210 0.0329
143 INTERVERTEBRAL DISC DEGENERATION 305 0.0329
144 FEELING OF BODY TEMPERATURE CHANGE 193 0.0329
145 TYPE 1 DIABETES MELLITUS 197 0.0327
146 TENSION 199 0.0326
147 SELF-INJURIOUS IDEATION 137 0.0326
148 FEELING DRUNK 242 0.0325
149 SNORING 123 0.0325
150 MENTAL DISORDER 1413 0.0324
151 TOXICITY TO VARIOUS AGENTS 5463 0.0324
152 VITAMIN B12 DEFICIENCY 130 0.0321
153 HALLUCINATION, VISUAL 672 0.0318
154 INCONTINENCE 336 0.0318
155 COMMUNICATION DISORDER 121 0.0316
156 DRUG SCREEN POSITIVE 250 0.0316
157 SARCOIDOSIS 150 0.0315
158 WHEEZING 1870 0.0315
159 ANXIETY 8957 0.0314
160 SOCIAL AVOIDANT BEHAVIOUR 179 0.0309
161 HYPERSOMNIA 882 0.0307
162 HALLUCINATION 2311 0.0306
163 MIDDLE INSOMNIA 572 0.0306
164 DYSPHORIA 155 0.0306
165 GLUCOSE TOLERANCE IMPAIRED 180 0.0304
166 BRADYPHRENIA 198 0.0303
167 HYPERTONIA 173 0.0302
168 PNEUMONIA ASPIRATION 753 0.0301
169 NIGHTMARE 1042 0.0301
170 HYPERPHAGIA 120 0.0301
171 PRODUCT ADMINISTRATION INTERRUPTED 236 0.0300
172 CARDIAC MURMUR 260 0.0300
173 SPINAL OSTEOARTHRITIS 263 0.0299
174 DRUG INTERACTION 4722 0.0297
175 CONVULSION 1695 0.0296
176 BLOOD TEST ABNORMAL 416 0.0296
177 DEPRESSED LEVEL OF CONSCIOUSNESS 1168 0.0295
178 INITIAL INSOMNIA 302 0.0294
179 AFFECTIVE DISORDER 231 0.0294
180 RESPIRATORY TRACT INFECTION 765 0.0293
181 CEREBRAL ATROPHY 117 0.0293
182 BRAIN INJURY 294 0.0293
183 OEDEMA 1580 0.0291
184 INCOHERENT 188 0.0290
185 SOMNOLENCE 5839 0.0290
186 DYSARTHRIA 1091 0.0290
187 SKIN LACERATION 314 0.0288
188 NERVOUSNESS 1499 0.0287
189 INTENTIONAL OVERDOSE 1836 0.0286
190 ALTERED STATE OF CONSCIOUSNESS 620 0.0286
191 IRRITABILITY 1716 0.0285
192 DYSGRAPHIA 186 0.0282
193 FORMICATION 195 0.0280
194 ARTERIOSCLEROSIS CORONARY ARTERY 185 0.0279
195 INTERVERTEBRAL DISC PROTRUSION 610 0.0279
196 AMNESIA 1811 0.0278
197 MUSCLE TWITCHING 640 0.0277
198 MENTAL IMPAIRMENT 673 0.0277
199 DRUG LEVEL ABOVE THERAPEUTIC 127 0.0277
200 OBESITY 441 0.0277
201 TARDIVE DYSKINESIA 776 0.0275
202 POOR QUALITY SLEEP 592 0.0275
203 ABNORMAL DREAMS 758 0.0274
204 PRESCRIBED OVERDOSE 531 0.0274
205 SPUTUM DISCOLOURED 260 0.0274
206 MENTAL STATUS CHANGES 761 0.0274
207 OBSTRUCTIVE AIRWAYS DISORDER 304 0.0273
208 BALANCE DISORDER 2362 0.0273
209 GRAND MAL CONVULSION 252 0.0273
210 HYPOKINESIA 395 0.0272
211 DISTURBANCE IN ATTENTION 1467 0.0272
212 DRUG DIVERSION 167 0.0270
213 ASPIRATION 296 0.0270
214 AFFECT LABILITY 260 0.0270
215 INSOMNIA 7179 0.0269
216 TREMOR 4460 0.0268
217 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1289 0.0268
218 FEELING JITTERY 510 0.0267
219 PERSONALITY CHANGE 248 0.0267
220 SKIN ABRASION 126 0.0266
221 DRUG TOXICITY 363 0.0266
222 COMA 1269 0.0266
223 PSYCHOMOTOR HYPERACTIVITY 441 0.0265
224 COGNITIVE DISORDER 1240 0.0265
225 EUPHORIC MOOD 272 0.0265
226 SPEECH DISORDER 1391 0.0265
227 MOOD ALTERED 721 0.0264
228 ECONOMIC PROBLEM 399 0.0263
229 FEAR 697 0.0259
230 DISORIENTATION 1021 0.0257
231 MUSCLE DISORDER 208 0.0257
232 SENSORY LOSS 206 0.0256
233 HYPERTHERMIA 195 0.0255
234 BLOOD TRIGLYCERIDES INCREASED 451 0.0255
235 HYPOTHERMIA 258 0.0255
236 PSYCHIATRIC SYMPTOM 188 0.0254
237 NEURALGIA 617 0.0253
238 PERONEAL NERVE PALSY 144 0.0253
239 BLOOD IRON DECREASED 297 0.0250
240 TROPONIN INCREASED 189 0.0248
241 VITAMIN D DEFICIENCY 242 0.0248
242 BLOOD PROLACTIN INCREASED 116 0.0246
243 SCOLIOSIS 152 0.0245
244 LIGAMENT SPRAIN 242 0.0244
245 SINUS TACHYCARDIA 347 0.0244
246 ORTHOSTATIC HYPOTENSION 425 0.0244
247 HYPOTONIA 243 0.0243
248 HEAD INJURY 765 0.0241
249 MOTOR DYSFUNCTION 246 0.0241
250 RIB FRACTURE 496 0.0241
251 MOVEMENT DISORDER 772 0.0240
252 HYPERPROLACTINAEMIA 155 0.0239
253 LETHARGY 1373 0.0238
254 RALES 138 0.0237
255 DRUG ABUSER 146 0.0237
256 MOOD SWINGS 757 0.0237
257 BACK INJURY 258 0.0237
258 INTENTIONAL SELF-INJURY 479 0.0237
259 ACTIVITIES OF DAILY LIVING IMPAIRED 469 0.0237
260 INTENTIONAL DRUG MISUSE 495 0.0237
261 TRICUSPID VALVE INCOMPETENCE 188 0.0236
262 PAROSMIA 178 0.0236
263 ENCEPHALOPATHY 579 0.0236
264 BLOOD PRESSURE DIASTOLIC DECREASED 174 0.0235
265 DRUG WITHDRAWAL SYNDROME 2059 0.0234
266 HYPOTHYROIDISM 748 0.0234
267 ASTHMA 2645 0.0234
268 AMMONIA INCREASED 119 0.0233
269 URINARY INCONTINENCE 689 0.0232
270 IMPAIRED GASTRIC EMPTYING 317 0.0232
271 DIABETES MELLITUS 1771 0.0232
272 SPINAL DISORDER 220 0.0232
273 EPILEPSY 710 0.0232
274 CARDIAC ARREST 1917 0.0232
275 NONSPECIFIC REACTION 127 0.0231
276 NEUTROPHIL COUNT INCREASED 236 0.0230
277 BLOOD SODIUM DECREASED 434 0.0230
278 DRUG LEVEL INCREASED 381 0.0230
279 GASTROOESOPHAGEAL REFLUX DISEASE 1847 0.0229
280 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 389 0.0229
281 BLOOD PRESSURE SYSTOLIC INCREASED 443 0.0227
282 DEPRESSED MOOD 1200 0.0227
283 EATING DISORDER 483 0.0227
284 ROAD TRAFFIC ACCIDENT 946 0.0226
285 BLOOD CHOLESTEROL INCREASED 1052 0.0225
286 LIMB INJURY 612 0.0225
287 DENTAL CARIES 249 0.0225
288 HYPOAESTHESIA ORAL 338 0.0224
289 CHRONIC KIDNEY DISEASE 1701 0.0224
290 SLEEP DISORDER 1579 0.0223
291 DELIRIUM 775 0.0223
292 CHOLELITHIASIS 730 0.0222
293 TOOTH FRACTURE 245 0.0222
294 APNOEA 173 0.0222
295 HIATUS HERNIA 287 0.0221
296 MEMORY IMPAIRMENT 3043 0.0221
297 EMOTIONAL DISORDER 679 0.0220
298 DECUBITUS ULCER 179 0.0219
299 HYPERVENTILATION 127 0.0219
300 BEDRIDDEN 286 0.0217
301 END STAGE RENAL DISEASE 396 0.0217
302 MICTURITION URGENCY 247 0.0216
303 ENERGY INCREASED 127 0.0215
304 MIGRAINE 2040 0.0213
305 ANAL INCONTINENCE 192 0.0213
306 PRODUCT SUBSTITUTION ISSUE 1228 0.0213
307 APATHY 311 0.0213
308 TEMPERATURE INTOLERANCE 220 0.0213
309 VITAMIN D DECREASED 182 0.0213
310 WRIST FRACTURE 255 0.0213
311 CHOLECYSTITIS CHRONIC 142 0.0212
312 PULMONARY CONGESTION 279 0.0211
313 EAR PAIN 411 0.0211
314 SLUGGISHNESS 215 0.0211
315 CONFUSIONAL STATE 3402 0.0210
316 EYE MOVEMENT DISORDER 144 0.0210
317 MUSCLE TIGHTNESS 339 0.0209
318 TINNITUS 961 0.0209
319 HAND FRACTURE 148 0.0209
320 SEXUAL DYSFUNCTION 244 0.0208
321 JOINT INJURY 443 0.0207
322 FALL 6901 0.0207
323 TONGUE DISORDER 150 0.0207
324 CEREBRAL DISORDER 153 0.0207
325 BLEPHAROSPASM 130 0.0206
326 WEIGHT INCREASED 4616 0.0206
327 ANKLE FRACTURE 319 0.0206
328 SECRETION DISCHARGE 258 0.0206
329 MUSCLE SPASTICITY 253 0.0206
330 URINARY RETENTION 687 0.0206
331 SINUS DISORDER 407 0.0205
332 FOOT FRACTURE 389 0.0205
333 RESPIRATORY RATE INCREASED 182 0.0205
334 INCREASED APPETITE 391 0.0204
335 BRAIN OEDEMA 258 0.0204
336 APHASIA 616 0.0204
337 WALKING AID USER 133 0.0202
338 HYPERHIDROSIS 2595 0.0201
339 ATELECTASIS 193 0.0200
340 HEPATIC STEATOSIS 372 0.0200
341 BODY HEIGHT DECREASED 213 0.0199
342 EMPHYSEMA 200 0.0198
343 GAIT DISTURBANCE 3794 0.0198
344 ELECTROCARDIOGRAM QT PROLONGED 713 0.0198
345 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1033 0.0198
346 NERVE INJURY 220 0.0198
347 FEELING ABNORMAL 4739 0.0198
348 JOINT DISLOCATION 208 0.0197
349 BODY TEMPERATURE INCREASED 401 0.0196
350 IMPAIRED WORK ABILITY 419 0.0196
351 DYSSTASIA 572 0.0196
352 SEASONAL ALLERGY 277 0.0196
353 ARTERIOSCLEROSIS 184 0.0195
354 RENAL CYST 155 0.0195
355 DIPLOPIA 506 0.0195
356 THERMAL BURN 138 0.0194
357 OSTEOARTHRITIS 821 0.0193
358 LARGE INTESTINE POLYP 134 0.0193
359 BLADDER DISORDER 192 0.0193
360 BLOOD CREATINE PHOSPHOKINASE INCREASED 556 0.0193
361 THERAPEUTIC RESPONSE UNEXPECTED 865 0.0193
362 CARDIOMEGALY 236 0.0192
363 NECK PAIN 1072 0.0192
364 ASPHYXIA 156 0.0191
365 BODY TEMPERATURE DECREASED 187 0.0190
366 NERVE COMPRESSION 175 0.0189
367 LOSS OF CONSCIOUSNESS 2426 0.0189
368 HEAD DISCOMFORT 335 0.0189
369 DRY MOUTH 1533 0.0189
370 HEREDITARY ANGIOEDEMA 202 0.0188
371 DYSURIA 692 0.0188
372 MUSCLE STRAIN 162 0.0187
373 LACERATION 176 0.0187
374 BRONCHITIS 1381 0.0186
375 MYOPATHY 161 0.0186
376 EXOSTOSIS 170 0.0186
377 FACIAL PAIN 166 0.0186
378 TOXIC EPIDERMAL NECROLYSIS 282 0.0186
379 DIABETES MELLITUS INADEQUATE CONTROL 328 0.0185
380 SINUS BRADYCARDIA 179 0.0185
381 PARALYSIS 265 0.0185
382 HEART RATE INCREASED 1831 0.0185
383 BREAST MASS 124 0.0184
384 DIVERTICULUM 131 0.0184
385 APPETITE DISORDER 122 0.0184
386 HYPERAESTHESIA 151 0.0184
387 HYSTERECTOMY 159 0.0183
388 OSTEOPENIA 278 0.0183
389 ANOREXIA 236 0.0183
390 FULL BLOOD COUNT ABNORMAL 192 0.0181
391 SENSORY DISTURBANCE 289 0.0180
392 NOCTURIA 218 0.0179
393 MITRAL VALVE INCOMPETENCE 203 0.0179
394 HYPERCHOLESTEROLAEMIA 173 0.0179
395 REFUSAL OF TREATMENT BY PATIENT 117 0.0179
396 IRRITABLE BOWEL SYNDROME 384 0.0179
397 WEIGHT FLUCTUATION 186 0.0178
398 DYSPHAGIA 1687 0.0178
399 ROTATOR CUFF SYNDROME 228 0.0177
400 SKIN INFECTION 198 0.0176
401 BURNING SENSATION 1235 0.0176
402 MENSTRUAL DISORDER 145 0.0175
403 ANHEDONIA 460 0.0175
404 FACIAL PARALYSIS 149 0.0175
405 GASTROINTESTINAL PAIN 192 0.0174
406 GASTRITIS 459 0.0174
407 MALNUTRITION 195 0.0174
408 DECREASED ACTIVITY 188 0.0174
409 CYANOSIS 273 0.0173
410 QUALITY OF LIFE DECREASED 232 0.0173
411 ABASIA 427 0.0173
412 WEIGHT DECREASED 4819 0.0172
413 PULMONARY MASS 257 0.0172
414 PRODUCTIVE COUGH 822 0.0172
415 ELECTROCARDIOGRAM ABNORMAL 135 0.0172
416 WRONG TECHNIQUE IN DRUG USAGE PROCESS 625 0.0172
417 FRUSTRATION TOLERANCE DECREASED 139 0.0172
418 POLLAKIURIA 708 0.0170
419 CONTUSION 1634 0.0170
420 BLOOD PRESSURE FLUCTUATION 407 0.0169
421 GASTROENTERITIS VIRAL 306 0.0169
422 BRADYCARDIA 898 0.0169
423 MUSCULOSKELETAL CHEST PAIN 262 0.0169
424 SPINAL PAIN 198 0.0169
425 MULTIPLE ALLERGIES 132 0.0168
426 OXYGEN SATURATION DECREASED 944 0.0168
427 HAEMORRHOIDS 327 0.0167
428 BLOOD POTASSIUM DECREASED 504 0.0167
429 EXTRAPYRAMIDAL DISORDER 416 0.0167
430 PHOTOPHOBIA 315 0.0167
431 NIGHT SWEATS 538 0.0167
432 DISABILITY 330 0.0167
433 TREATMENT NONCOMPLIANCE 912 0.0167
434 SINUSITIS 1706 0.0166
435 INTENTIONAL UNDERDOSE 121 0.0165
436 MUSCULAR WEAKNESS 1882 0.0165
437 URINARY TRACT INFECTION 2821 0.0165
438 NEPHROLITHIASIS 758 0.0165
439 UPPER LIMB FRACTURE 329 0.0165
440 SCIATICA 263 0.0165
441 VERTIGO 1005 0.0165
442 RHABDOMYOLYSIS 687 0.0165
443 HEART RATE DECREASED 578 0.0164
444 CHEST PAIN 3042 0.0164
445 HEART RATE IRREGULAR 371 0.0164
446 INTENTIONAL PRODUCT MISUSE 1436 0.0164
447 SINUS CONGESTION 221 0.0163
448 PRESCRIBED UNDERDOSE 325 0.0163
449 MUSCLE SPASMS 2987 0.0163
450 BLOOD URINE PRESENT 309 0.0163
451 TACHYCARDIA 1446 0.0163
452 PNEUMONIA 5269 0.0163
453 CYSTITIS 516 0.0162
454 COLD SWEAT 285 0.0162
455 SOPOR 214 0.0161
456 LEUKOCYTOSIS 292 0.0161
457 CONSTIPATION 3512 0.0161
458 INCREASED TENDENCY TO BRUISE 148 0.0161
459 INFLUENZA LIKE ILLNESS 1323 0.0161
460 MULTIPLE SCLEROSIS 768 0.0160
461 CHOKING 313 0.0160
462 INFUSION SITE ERYTHEMA 135 0.0160
463 THIRST 286 0.0160
464 FEELING COLD 444 0.0159
465 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 873 0.0159
466 SCAR 272 0.0159
467 BACK DISORDER 258 0.0159
468 OSTEOPOROSIS 652 0.0158
469 THYROID DISORDER 244 0.0158
470 MYOCARDITIS 181 0.0158
471 VISION BLURRED 2165 0.0158
472 GALLBLADDER DISORDER 281 0.0157
473 HYPOAESTHESIA 2353 0.0157
474 TOOTH ABSCESS 160 0.0157
475 DIZZINESS POSTURAL 152 0.0157
476 HEPATOMEGALY 154 0.0157
477 NEPHROPATHY 146 0.0156
478 HYPOPHAGIA 399 0.0156
479 ACIDOSIS 119 0.0156
480 MUSCULOSKELETAL STIFFNESS 1356 0.0155
481 OVERDOSE 3338 0.0155
482 HUNGER 215 0.0154
483 PHARYNGITIS STREPTOCOCCAL 167 0.0154
484 NERVOUS SYSTEM DISORDER 481 0.0154
485 PALPITATIONS 1804 0.0154
486 PHARYNGITIS 191 0.0154
487 FEEDING DISORDER 312 0.0154
488 RENAL FAILURE CHRONIC 118 0.0153
489 HAEMATOCRIT DECREASED 304 0.0153
490 TOOTHACHE 277 0.0153
491 MULTIPLE SCLEROSIS RELAPSE 1048 0.0153
492 WHITE BLOOD CELL COUNT INCREASED 582 0.0152
493 MASS 212 0.0152
494 INTENTIONAL PRODUCT USE ISSUE 1326 0.0151
495 RHINITIS 122 0.0151
496 DRUG LEVEL DECREASED 154 0.0151
497 VENTRICULAR EXTRASYSTOLES 157 0.0151
498 EAR INFECTION 402 0.0151
499 DEMENTIA 421 0.0150
500 PSYCHOLOGICAL TRAUMA 130 0.0150
501 RETCHING 321 0.0150
502 BLOOD PRESSURE INCREASED 2298 0.0150
503 PULMONARY OEDEMA 673 0.0150
504 BLOOD POTASSIUM INCREASED 244 0.0150
505 CELLULITIS 756 0.0150
506 BACK PAIN 3484 0.0150
507 DIZZINESS 7466 0.0150
508 ACCIDENT 178 0.0149
509 HYPOTENSION 2989 0.0149
510 COELIAC DISEASE 146 0.0149
511 CHOLECYSTECTOMY 170 0.0149
512 SMALL INTESTINAL OBSTRUCTION 183 0.0149
513 CENTRAL NERVOUS SYSTEM LESION 204 0.0148
514 DRUG EFFECT DECREASED 798 0.0148
515 PARAESTHESIA 2328 0.0148
516 FOOT DEFORMITY 164 0.0148
517 HYPERGLYCAEMIA 533 0.0146
518 BURSITIS 177 0.0146
519 BLOOD PRESSURE DECREASED 968 0.0146
520 HYPERTENSION 3075 0.0145
521 PHOTOSENSITIVITY REACTION 239 0.0145
522 MUSCLE ATROPHY 183 0.0144
523 GRIP STRENGTH DECREASED 127 0.0144
524 FEELING HOT 884 0.0144
525 IMPAIRED QUALITY OF LIFE 207 0.0144
526 VENTRICULAR TACHYCARDIA 237 0.0143
527 IRON DEFICIENCY ANAEMIA 132 0.0143
528 FLANK PAIN 134 0.0143
529 OEDEMA PERIPHERAL 1740 0.0143
530 MUSCULOSKELETAL DISCOMFORT 245 0.0142
531 RENAL DISORDER 662 0.0142
532 VOMITING 6674 0.0142
533 MALAISE 6224 0.0142
534 VENTRICULAR FIBRILLATION 157 0.0141
535 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 242 0.0141
536 ORAL DISCOMFORT 196 0.0141
537 DEHYDRATION 1879 0.0141
538 CONDITION AGGRAVATED 4281 0.0141
539 HAIR DISORDER 116 0.0141
540 RENAL INJURY 418 0.0141
541 HEADACHE 8819 0.0141
542 RESPIRATORY FAILURE 1025 0.0140
543 BONE DISORDER 256 0.0140
544 EAR DISCOMFORT 144 0.0140
545 PERIPHERAL COLDNESS 192 0.0140
546 GAIT INABILITY 467 0.0140
547 TRANSIENT ISCHAEMIC ATTACK 471 0.0139
548 DERMATITIS CONTACT 159 0.0139
549 RED BLOOD CELL SEDIMENTATION RATE INCREASED 154 0.0139
550 OVARIAN CYST 139 0.0139
551 DYSPHONIA 812 0.0139
552 HYPOXIA 488 0.0138
553 ABDOMINAL DISTENSION 1446 0.0138
554 RESPIRATORY DISTRESS 382 0.0138
555 CARDIOMYOPATHY 204 0.0138
556 CYST 171 0.0138
557 NASAL CONGESTION 807 0.0137
558 TENDERNESS 143 0.0137
559 ERECTILE DYSFUNCTION 352 0.0137
560 UPPER RESPIRATORY TRACT INFECTION 633 0.0137
561 LYMPHOCYTE COUNT DECREASED 242 0.0137
562 PRODUCT TASTE ABNORMAL 185 0.0136
563 INADEQUATE ANALGESIA 116 0.0136
564 JOINT RANGE OF MOTION DECREASED 183 0.0136
565 ASTHENIA 5128 0.0136
566 RED BLOOD CELL COUNT DECREASED 389 0.0136
567 FATIGUE 10591 0.0136
568 RESPIRATORY TRACT CONGESTION 216 0.0136
569 DYSPEPSIA 1337 0.0136
570 ACUTE RESPIRATORY DISTRESS SYNDROME 240 0.0136
571 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 964 0.0135
572 PAIN 8324 0.0135
573 BLOOD PRESSURE ABNORMAL 269 0.0135
574 HYPOGLYCAEMIA 655 0.0135
575 RENAL PAIN 143 0.0135
576 HEPATOTOXICITY 300 0.0135
577 EOSINOPHILIA 236 0.0135
578 ORAL CANDIDIASIS 177 0.0134
579 UNEVALUABLE EVENT 1017 0.0134
580 BLOOD UREA INCREASED 225 0.0134
581 DEVELOPMENTAL DELAY 121 0.0134
582 LIMB DISCOMFORT 415 0.0134
583 HEMIPARESIS 227 0.0134
584 PANCREATITIS 708 0.0134
585 LOCAL SWELLING 233 0.0133
586 KIDNEY INFECTION 262 0.0133
587 COUGH 3744 0.0133
588 EYE PAIN 752 0.0133
589 TOOTH DISORDER 296 0.0133
590 INFLUENZA 1483 0.0133
591 GASTRIC DISORDER 454 0.0132
592 PALLOR 360 0.0132
593 HIP FRACTURE 425 0.0132
594 BLOOD ALKALINE PHOSPHATASE INCREASED 328 0.0132
595 DECREASED APPETITE 3065 0.0132
596 BREAST PAIN 140 0.0131
597 ACCIDENTAL OVERDOSE 480 0.0131
598 RHINORRHOEA 844 0.0130
599 PHARMACEUTICAL PRODUCT COMPLAINT 339 0.0130
600 SWOLLEN TONGUE 407 0.0130
601 HOSPICE CARE 128 0.0129
602 INJURY 909 0.0129
603 SYNCOPE 1293 0.0129
604 BLOOD BILIRUBIN INCREASED 349 0.0129
605 ELECTROLYTE IMBALANCE 150 0.0129
606 FLATULENCE 732 0.0129
607 TOOTH INFECTION 170 0.0129
608 MOBILITY DECREASED 925 0.0129
609 RENAL FAILURE 1708 0.0128
610 DRY EYE 642 0.0128
611 CORONARY ARTERY OCCLUSION 176 0.0128
612 OROPHARYNGEAL PAIN 1185 0.0128
613 NEUROPATHY PERIPHERAL 1214 0.0128
614 OSTEOMYELITIS 231 0.0127
615 EYE INFECTION 144 0.0127
616 INSURANCE ISSUE 195 0.0127
617 BRAIN FOG 199 0.0127
618 ABDOMINAL PAIN UPPER 2611 0.0127
619 DYSPNOEA 7174 0.0127
620 PAIN IN EXTREMITY 3734 0.0127
621 CHILLS 1483 0.0126
622 SUPRAVENTRICULAR TACHYCARDIA 121 0.0126
623 OESOPHAGITIS 138 0.0126
624 SPINAL FRACTURE 252 0.0126
625 GASTROENTERITIS 183 0.0125
626 NAUSEA 9904 0.0125
627 ULCER 199 0.0125
628 INFUSION SITE PAIN 161 0.0125
629 CHEST DISCOMFORT 1279 0.0125
630 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 128 0.0125
631 PAIN IN JAW 353 0.0124
632 HYPOKALAEMIA 574 0.0124
633 SPINAL OPERATION 153 0.0124
634 POST PROCEDURAL COMPLICATION 238 0.0124
635 ASPARTATE AMINOTRANSFERASE INCREASED 658 0.0124
636 VIRAL INFECTION 412 0.0124
637 ARTHRITIS 972 0.0123
638 HEPATITIS C 149 0.0123
639 RENAL TUBULAR NECROSIS 121 0.0123
640 MUSCULOSKELETAL PAIN 644 0.0123
641 APHONIA 171 0.0122
642 STEVENS-JOHNSON SYNDROME 271 0.0122
643 CLOSTRIDIUM DIFFICILE COLITIS 129 0.0122
644 MUSCULOSKELETAL DISORDER 231 0.0121
645 BLOOD CALCIUM DECREASED 136 0.0121
646 PHARYNGEAL SWELLING 118 0.0120
647 THERAPY PARTIAL RESPONDER 188 0.0120
648 LYMPHADENOPATHY 424 0.0120
649 PRESYNCOPE 291 0.0120
650 RESPIRATORY DISORDER 358 0.0120
651 GENERALISED OEDEMA 148 0.0119
652 SPLENOMEGALY 140 0.0119
653 ORAL PAIN 267 0.0119
654 STAPHYLOCOCCAL INFECTION 393 0.0119
655 HEPATIC ENZYME INCREASED 812 0.0119
656 EYELID PTOSIS 121 0.0119
657 VISUAL IMPAIRMENT 1475 0.0119
658 KNEE OPERATION 117 0.0119
659 GLAUCOMA 229 0.0119
660 TENDONITIS 184 0.0119
661 ABDOMINAL PAIN 2763 0.0119
662 CARDIAC DISORDER 1111 0.0119
663 SKIN DISCOLOURATION 541 0.0118
664 DRUG DEPENDENCE 1887 0.0117
665 DRY THROAT 119 0.0117
666 POOR VENOUS ACCESS 121 0.0117
667 PRODUCT AVAILABILITY ISSUE 266 0.0117
668 SCRATCH 123 0.0116
669 COAGULOPATHY 194 0.0116
670 FUNGAL INFECTION 388 0.0116
671 MYALGIA 1979 0.0116
672 PERIPHERAL SWELLING 1793 0.0116
673 BONE PAIN 681 0.0116
674 EYE DISORDER 381 0.0116
675 ABDOMINAL DISCOMFORT 1942 0.0116
676 DIABETIC KETOACIDOSIS 278 0.0116
677 DRUG PRESCRIBING ERROR 222 0.0115
678 CHROMATURIA 260 0.0115
679 ALANINE AMINOTRANSFERASE INCREASED 707 0.0115
680 TOOTH EXTRACTION 143 0.0115
681 ORAL HERPES 224 0.0115
682 DYSPNOEA EXERTIONAL 432 0.0115
683 DEEP VEIN THROMBOSIS 745 0.0115
684 ACUTE RESPIRATORY FAILURE 220 0.0114
685 CATARACT 681 0.0114
686 LOCALISED INFECTION 276 0.0114
687 METABOLIC ACIDOSIS 363 0.0113
688 LOWER LIMB FRACTURE 218 0.0113
689 ANGINA PECTORIS 325 0.0113
690 DRUG RESISTANCE 290 0.0113
691 HAIR COLOUR CHANGES 140 0.0112
692 CLOSTRIDIUM DIFFICILE INFECTION 245 0.0112
693 HOT FLUSH 845 0.0112
694 PRODUCT PHYSICAL ISSUE 226 0.0112
695 DYSGEUSIA 831 0.0112
696 HYPONATRAEMIA 626 0.0111
697 ILEUS 138 0.0111
698 DRUG DOSE OMISSION 1835 0.0111
699 THROAT IRRITATION 498 0.0111
700 WOUND 310 0.0111
701 ACUTE KIDNEY INJURY 1691 0.0110
702 PARAESTHESIA ORAL 159 0.0110
703 MEDICATION ERROR 612 0.0110
704 PRURITUS GENERALISED 238 0.0110
705 DIVERTICULITIS 304 0.0110
706 LOWER RESPIRATORY TRACT INFECTION 498 0.0109
707 DEVICE OCCLUSION 154 0.0109
708 HAIR TEXTURE ABNORMAL 146 0.0109
709 CARDIOGENIC SHOCK 156 0.0109
710 CHOLECYSTITIS 129 0.0108
711 TACHYPNOEA 147 0.0108
712 ILLNESS 1113 0.0108
713 IMMUNODEFICIENCY 161 0.0108
714 PHARYNGEAL OEDEMA 166 0.0108
715 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 766 0.0108
716 HERNIA 208 0.0107
717 GASTROINTESTINAL DISORDER 963 0.0107
718 ARRHYTHMIA 509 0.0107
719 DRUG INEFFECTIVE 14148 0.0107
720 HAEMOPTYSIS 299 0.0107
721 SCAB 122 0.0107
722 BLISTER 600 0.0107
723 FLUSHING 1085 0.0107
724 RASH PAPULAR 239 0.0107
725 SKIN LESION 292 0.0106
726 MYOCARDIAL ISCHAEMIA 121 0.0106
727 DIARRHOEA 6863 0.0106
728 ARTHRALGIA 4416 0.0106
729 RECTAL HAEMORRHAGE 455 0.0106
730 PYREXIA 3659 0.0106
731 PELVIC PAIN 192 0.0106
732 NEOPLASM 121 0.0105
733 ARTHROPATHY 585 0.0105
734 NASOPHARYNGITIS 1935 0.0105
735 HERPES ZOSTER 603 0.0105
736 IMMUNE SYSTEM DISORDER 138 0.0105
737 THERAPY CESSATION 535 0.0104
738 TUBULOINTERSTITIAL NEPHRITIS 195 0.0104
739 PRODUCT USE IN UNAPPROVED INDICATION 2572 0.0104
740 PNEUMOTHORAX 164 0.0103
741 THROAT TIGHTNESS 279 0.0103
742 CANDIDA INFECTION 174 0.0103
743 PULMONARY EMBOLISM 977 0.0103
744 FREQUENT BOWEL MOVEMENTS 277 0.0102
745 SKIN DISORDER 342 0.0102
746 BRONCHOSPASM 146 0.0102
747 BLOOD LACTATE DEHYDROGENASE INCREASED 162 0.0102
748 CORONARY ARTERY DISEASE 309 0.0102
749 RENAL FAILURE ACUTE 433 0.0102
750 HAEMOGLOBIN DECREASED 1045 0.0102
751 SWELLING FACE 662 0.0102
752 PANCREATITIS ACUTE 228 0.0101
753 NODULE 132 0.0101
754 DISCOMFORT 617 0.0101
755 HAEMATOMA 262 0.0101
756 JOINT SWELLING 1217 0.0101
757 JOINT STIFFNESS 264 0.0101
758 INTESTINAL OBSTRUCTION 379 0.0100
759 TOOTH LOSS 208 0.0100
760 HYPERTHYROIDISM 144 0.0099
761 NO THERAPEUTIC RESPONSE 121 0.0099
762 PROCEDURAL PAIN 274 0.0099
763 SURGERY 579 0.0099
764 DRUG EFFECT LESS THAN EXPECTED 146 0.0098
765 PREGNANCY 197 0.0098
766 BLOOD COUNT ABNORMAL 149 0.0098
767 HAEMATURIA 335 0.0098
768 DRUG EFFECT INCOMPLETE 355 0.0098
769 THERAPEUTIC RESPONSE SHORTENED 324 0.0098
770 C-REACTIVE PROTEIN INCREASED 353 0.0097
771 SHOCK 223 0.0097
772 EMOTIONAL DISTRESS 1171 0.0097
773 FLUID RETENTION 491 0.0096
774 DEVICE RELATED INFECTION 148 0.0096
775 ALOPECIA 1880 0.0096
776 THERAPEUTIC RESPONSE DECREASED 580 0.0096
777 ERUCTATION 185 0.0096
778 ADRENAL INSUFFICIENCY 116 0.0095
779 HEPATIC FAILURE 288 0.0095
780 ILL-DEFINED DISORDER 580 0.0095
781 KNEE ARTHROPLASTY 200 0.0095
782 SNEEZING 213 0.0095
783 VISUAL ACUITY REDUCED 315 0.0095
784 FAECES DISCOLOURED 205 0.0094
785 GASTRIC ULCER 179 0.0094
786 EYE SWELLING 350 0.0094
787 HYPOACUSIS 404 0.0094
788 BLINDNESS UNILATERAL 132 0.0093
789 OFF LABEL USE 8149 0.0093
790 DRUG DISPENSING ERROR 142 0.0093
791 DRUG ADMINISTRATION ERROR 285 0.0093
792 EJECTION FRACTION DECREASED 144 0.0093
793 SWELLING 862 0.0092
794 MULTIPLE FRACTURES 151 0.0092
795 BACTERIAL INFECTION 171 0.0092
796 LUNG DISORDER 447 0.0091
797 LIVER FUNCTION TEST ABNORMAL 265 0.0091
798 DEAFNESS 238 0.0091
799 THERAPY NON-RESPONDER 409 0.0091
800 WHITE BLOOD CELL COUNT DECREASED 985 0.0091
801 PRODUCT DOSE OMISSION 591 0.0090
802 INTERNATIONAL NORMALISED RATIO INCREASED 257 0.0090
803 RASH GENERALISED 233 0.0090
804 PLATELET COUNT INCREASED 117 0.0090
805 GOUT 161 0.0090
806 ANKYLOSING SPONDYLITIS 118 0.0089
807 PRODUCT QUALITY ISSUE 1214 0.0089
808 RASH MACULAR 312 0.0089
809 GINGIVAL BLEEDING 121 0.0089
810 HAEMATEMESIS 224 0.0088
811 THERAPEUTIC PRODUCT EFFECT DECREASED 395 0.0088
812 PRODUCT USE ISSUE 1657 0.0088
813 GLOSSODYNIA 197 0.0088
814 LIP SWELLING 293 0.0088
815 BLINDNESS 358 0.0088
816 LACRIMATION INCREASED 265 0.0088
817 RASH ERYTHEMATOUS 419 0.0088
818 DRUG EXPOSURE DURING PREGNANCY 298 0.0088
819 INFLAMMATION 451 0.0087
820 ABSCESS 139 0.0087
821 DEVICE DISLOCATION 377 0.0087
822 GAMMA-GLUTAMYLTRANSFERASE INCREASED 192 0.0087
823 HAEMATOCHEZIA 478 0.0087
824 BLOOD CREATININE INCREASED 563 0.0086
825 INTENTIONAL DOSE OMISSION 245 0.0086
826 DRUG WITHDRAWAL SYNDROME NEONATAL 127 0.0086
827 FOETAL EXPOSURE DURING PREGNANCY 697 0.0086
828 DRUG INTOLERANCE 827 0.0086
829 LUNG INFECTION 133 0.0086
830 MOUTH ULCERATION 180 0.0085
831 SEPSIS 952 0.0085
832 PULMONARY HYPERTENSION 176 0.0084
833 CIRCULATORY COLLAPSE 143 0.0084
834 AMENORRHOEA 147 0.0084
835 IMPAIRED HEALING 275 0.0084
836 CONJUNCTIVITIS 155 0.0083
837 MULTI-ORGAN FAILURE 144 0.0083
838 CARDIAC FAILURE CONGESTIVE 669 0.0083
839 THROMBOSIS 667 0.0083
840 ANAEMIA 1579 0.0083
841 PRURITUS 3179 0.0083
842 URTICARIA 1372 0.0082
843 HOSPITALISATION 1254 0.0082
844 LEUKOPENIA 408 0.0081
845 ABDOMINAL PAIN LOWER 206 0.0081
846 EPISTAXIS 608 0.0081
847 LIVER DISORDER 358 0.0081
848 PERICARDIAL EFFUSION 186 0.0080
849 PRODUCT ADMINISTRATION ERROR 162 0.0080
850 BASAL CELL CARCINOMA 125 0.0080
851 MENORRHAGIA 157 0.0080
852 RASH PRURITIC 433 0.0080
853 PRODUCT PRESCRIBING ERROR 190 0.0080
854 SKIN ULCER 205 0.0079
855 SKIN HAEMORRHAGE 117 0.0079
856 ATRIAL FIBRILLATION 768 0.0079
857 INFECTION 1137 0.0078
858 ADVERSE DRUG REACTION 705 0.0078
859 FACE OEDEMA 132 0.0078
860 ADVERSE EVENT 720 0.0078
861 HYPERSENSITIVITY 1450 0.0078
862 PRODUCT USE COMPLAINT 123 0.0078
863 PSORIATIC ARTHROPATHY 313 0.0077
864 RASH 3346 0.0077
865 FRACTURE 145 0.0077
866 COLITIS 290 0.0076
867 SKIN CANCER 163 0.0076
868 RHEUMATOID ARTHRITIS 859 0.0076
869 NEUROTOXICITY 131 0.0075
870 GENERAL PHYSICAL HEALTH DETERIORATION 857 0.0074
871 CEREBROVASCULAR ACCIDENT 1254 0.0074
872 STOMATITIS 448 0.0074
873 PNEUMONITIS 201 0.0074
874 INCORRECT DRUG ADMINISTRATION DURATION 207 0.0074
875 AGEUSIA 183 0.0073
876 PRODUCT DOSE OMISSION ISSUE 2156 0.0073
877 HEPATITIS 187 0.0073
878 SEPTIC SHOCK 318 0.0073
879 SYSTEMIC LUPUS ERYTHEMATOSUS 259 0.0073
880 AGRANULOCYTOSIS 135 0.0073
881 EYE IRRITATION 416 0.0072
882 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1302 0.0072
883 PRODUCT ADHESION ISSUE 258 0.0072
884 DISEASE RECURRENCE 343 0.0072
885 INFUSION RELATED REACTION 475 0.0072
886 COVID-19 1256 0.0072
887 FEMUR FRACTURE 221 0.0071
888 PLEURAL EFFUSION 434 0.0071
889 BLOOD GLUCOSE DECREASED 342 0.0071
890 TRANSAMINASES INCREASED 158 0.0071
891 LIVER INJURY 174 0.0071
892 UNDERDOSE 517 0.0071
893 APPLICATION SITE ERYTHEMA 182 0.0069
894 HAEMORRHAGE 725 0.0069
895 MULTIPLE ORGAN DYSFUNCTION SYNDROME 196 0.0069
896 ERYTHEMA 1415 0.0069
897 VAGINAL HAEMORRHAGE 298 0.0069
898 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 176 0.0068
899 PULMONARY FIBROSIS 131 0.0068
900 PLATELET COUNT DECREASED 725 0.0068
901 MYOCARDIAL INFARCTION 1186 0.0068
902 ACUTE MYOCARDIAL INFARCTION 200 0.0068
903 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1372 0.0068
904 INJECTION SITE BRUISING 540 0.0068
905 LUNG NEOPLASM MALIGNANT 278 0.0068
906 GASTROINTESTINAL HAEMORRHAGE 564 0.0067
907 PRODUCT PRESCRIBING ISSUE 147 0.0067
908 GLYCOSYLATED HAEMOGLOBIN INCREASED 170 0.0067
909 DERMATITIS 141 0.0067
910 RENAL IMPAIRMENT 565 0.0067
911 LABORATORY TEST ABNORMAL 198 0.0067
912 PREMATURE BABY 201 0.0067
913 INCORRECT DOSE ADMINISTERED 1517 0.0066
914 PSORIASIS 858 0.0066
915 RASH MACULO-PAPULAR 146 0.0066
916 ANAPHYLACTIC REACTION 358 0.0065
917 OCULAR HYPERAEMIA 307 0.0065
918 EXPIRED PRODUCT ADMINISTERED 214 0.0064
919 EXPOSURE DURING PREGNANCY 399 0.0064
920 MATERNAL EXPOSURE DURING PREGNANCY 571 0.0064
921 HYPERKALAEMIA 223 0.0064
922 MENSTRUATION IRREGULAR 170 0.0063
923 BLOOD GLUCOSE INCREASED 1191 0.0063
924 EYE PRURITUS 212 0.0063
925 HEPATIC CIRRHOSIS 118 0.0063
926 THERAPY INTERRUPTED 448 0.0063
927 SKIN EXFOLIATION 528 0.0063
928 FULL BLOOD COUNT DECREASED 126 0.0062
929 INJECTION SITE MASS 230 0.0062
930 NEUTROPHIL COUNT DECREASED 252 0.0062
931 JAUNDICE 166 0.0062
932 SKIN FISSURES 120 0.0061
933 INJECTION SITE REACTION 420 0.0061
934 BONE DENSITY DECREASED 190 0.0061
935 LIVER FUNCTION TEST INCREASED 127 0.0059
936 DEVICE ISSUE 530 0.0059
937 PRODUCT DOSE OMISSION IN ERROR 166 0.0059
938 ABORTION SPONTANEOUS 234 0.0058
939 TASTE DISORDER 118 0.0058
940 APPLICATION SITE PRURITUS 129 0.0057
941 COLITIS ULCERATIVE 254 0.0057
942 HEPATIC FUNCTION ABNORMAL 212 0.0057
943 DRUG-INDUCED LIVER INJURY 174 0.0055
944 TREATMENT FAILURE 459 0.0055
945 INCORRECT PRODUCT ADMINISTRATION DURATION 120 0.0055
946 INJECTION SITE RASH 167 0.0054
947 CARDIAC FAILURE 432 0.0054
948 INJECTION SITE PRURITUS 356 0.0053
949 PAIN OF SKIN 143 0.0053
950 PANCYTOPENIA 296 0.0053
951 NEUTROPENIA 720 0.0053
952 THROMBOCYTOPENIA 587 0.0052
953 CARDIOVASCULAR DISORDER 133 0.0052
954 INJECTION SITE ERYTHEMA 647 0.0052
955 INJECTION SITE HAEMORRHAGE 415 0.0052
956 CEREBRAL HAEMORRHAGE 186 0.0052
957 INJECTION SITE PAIN 1581 0.0051
958 ASCITES 151 0.0051
959 DEATH 4378 0.0051
960 ECZEMA 265 0.0051
961 NEOPLASM MALIGNANT 337 0.0050
962 CEREBRAL INFARCTION 117 0.0048
963 BREAST CANCER 443 0.0047
964 OSTEONECROSIS 156 0.0047
965 DEVICE MALFUNCTION 333 0.0047
966 ACNE 359 0.0047
967 OSTEONECROSIS OF JAW 117 0.0047
968 DRY SKIN 625 0.0047
969 DISEASE PROGRESSION 554 0.0047
970 EXTRA DOSE ADMINISTERED 184 0.0045
971 INJECTION SITE SWELLING 346 0.0045
972 CONTRAINDICATED PRODUCT ADMINISTERED 135 0.0045
973 FEBRILE NEUTROPENIA 292 0.0044
974 SKIN BURNING SENSATION 308 0.0043
975 INCORRECT ROUTE OF DRUG ADMINISTRATION 150 0.0042
976 NEEDLE ISSUE 119 0.0041
977 DEPENDENCE 218 0.0040
978 PLASMA CELL MYELOMA 149 0.0038
979 DEVICE BREAKAGE 154 0.0038
980 GYNAECOMASTIA 117 0.0038
981 LACTIC ACIDOSIS 120 0.0037
982 NO ADVERSE EVENT 650 0.0036
983 NEOPLASM PROGRESSION 123 0.0035
984 INTERSTITIAL LUNG DISEASE 167 0.0034
985 DEVICE LEAKAGE 149 0.0034
986 ANGIOEDEMA 151 0.0034
987 DERMATITIS ATOPIC 166 0.0031
988 SKIN IRRITATION 138 0.0030
989 MALIGNANT NEOPLASM PROGRESSION 274 0.0027
990 ACCIDENTAL EXPOSURE TO PRODUCT 270 0.0026
991 PRODUCT STORAGE ERROR 147 0.0017